Multiple Sclerosis and Suicide Attempts: A Review including a Meta-Analysis of Prevalence
Table 3
Sensitivity analysis of studies in a systematic review on multiple sclerosis and suicide attempts.
Exclusion criteria
Included studies
Overall prev (95% CI)
CI length more than 0.1 Two studies excluded
Fisk et al., Feinstein, Korostil, et al., Stenager et al., Capkun et al., Brenner et al., Eliasen et al., Asgarian et al., Ouallet et al., Zhao et al., Sariaslani et al.
98%
0.03 (0.02-0.05)
CI length more than 0.06 Six studies excluded
Fisk et al., Stenager et al., Capkun et al., Brenner et al., Asgarian et al., Ouallet et al., Zhao et al.
98%
0.02 (0.01-0.03)
CI length more than 0.05 Eight studies excluded
Fisk et al., Stenager et al., Capkun et al., Brenner et al., Zhao et al.
99%
0.01 (0.00-0.02)
CI length less than 0.05 Five studies excluded
Sandyk et al., Feinstein, Korostil et al., de Cerqueira et al., Eliasen et al., Asgarian et al., Ouallet et al., Sariaslani et al.
69%
0.08 (0.05-0.11)
Weight less than 6% Three studies excluded
Fisk et al., Feinstein, Korostil et al., Stenager et al., Capkun et al., Brenner et al., Eliasen et al., Asgarian et al., Sariaslani et al., Zhao et al.
98%
0.03 (0.02-0.05)
Weight less than 8% Six studies excluded
Fisk et al., Stenager et al., Capkun et al., Brenner et al., Eliasen et al., Asgarian et al., Zhao et al.
99%
0.03 (0.01-0.04)
N less than 300 Six studies excluded Same studies as above
Fisk et al., Stenager et al., Capkun et al., Brenner et al., Eliasen, et al., Zhao et al., Asgarian et al.
99%
0.03 (0.01-0.04)
N more than 900 Four studies excluded
Sandyk et al., Feinstein, Korostil et al., Stenager et al., de Cerqueira et al., Eliasen et al., Asgarian et al., Ouallet et al., Sariaslani et al.
85%
0.07 (0.04-0.11)
Outliers excluded Three studies excluded
Fisk et al., Feinstein, Korostil et al., Stenager et al., de Cerqueira et al., Brenner et al., Asgarian et al., Ouallet et al., Sariaslani et al., Zhao et al.
91%
0.03 (0.02-0.05
Outliers excluded Six studies excluded
Feinstein, Korostil et al., Stenager et al., de Cerqueira, et al., Asgarian et al., Sariaslani et al., Zhao et al.
82%
0.05 (0.03-0.08)
Cross-sectional study design Five studies excluded
Sandyk et al., Fisk et al., Stenager et al., Capkun et al., de Cerqueira et al., Brenner et al., Eliasen et al., Ouallet et al.
99%
0.03 (0.01-0.05)
Cross-sectional or case-control study design Nine studies excluded
Sandyk et al., Stenager et al., Capkun et al., Ouallet et al.
94%
0.02 (0.00-0.07)
Cohort or case-control studies Eight studies excluded
Feinstein, Korostil et al., Asgarian et al., Sariaslani, et al., Zhao et al.
84%
0.06 (0.03-0.09)
Any follow-up but retrospective lifetime Seven studies excluded
Sandyk et al., Feinstein, Korostil et al., de Cerqueira et al., Asgarian, et al., Zhao et al.
83%
0.07 (0.03-0.11)
Any follow-up but retrospective of at least five years Five studies excluded
Sandyk et al., Feinstein, Korostil et al., de Cerqueira et al., Brenner et al., Eliasen et al., Asgarian et al., Zhao et al.
96%
0.07 (0.03-0.11)
Nonclinical studies Five studies excluded
Sandyk et al., Feinstein, Korostil et al., de Cerqueira et al., Asgarian et al., Ouallet et al., Sariaslani, et al., Zhao et al.
81%
0.06 (0.04-0.10)
Clinical studies Eight studies excluded
Fisk et al., Stenager et al., Capkun et al., Brenner et al., Eliasen et al.
99%
0.02 (0.01-0.04)
Antecedent studies, prior to 2000 Two studies excluded
Feinstein, Korostil et al., Stenager et al., Capkun et al., de Cerqueira et al., Brenner et al., Eliasen et al., Asgarian et al., Ouallet et al., Zhao et al., Sariaslani et al.
98%
0.04 (0.02-0.06)
Antecedent studies, prior to 2010 Four studies excluded
Stenager et al., Capkun et al., de Cerqueira et al., Brenner et al., Eliasen et al., Asgarian et al., Ouallet et al., Zhao et al., Sariaslani et al.
99%
0.04 (0.02-0.06)
Antecedent studies, prior to 2015 Five studies excluded
Capkun et al., de Cerqueira et al., Brenner et al., Eliasen et al., Asgarian et al., Ouallet et al., Zhao et al., Sariaslani et al.
99%
0.04 (0.02-0.07)
= -squared heterogeneity; prev = prevalence; CI 95% = confidence interval; = number of population.
